Skip to main content

About your Search

20130124
20130201
Search Results 0 to 1 of about 2
to get in or not. sue, down to you. >> thanks, guyes. president obama will nominate mary joe white to lead securities and exchange commission. he will do that later today. ms. white has broad experience, prosecuting white collar crimes. she was u.s. attorney in new york's southern district for a decade and she prosecuted the terrorist in the first world trade center attack in 1993. "street signs" will have that announcement coming up live in the next hour. ty? >> all right, sue. we are starting a brand new segment on "power lunch" today. we will go market to market across the country to see what for sale. what's tempting, like this big one here. and how far your money will go. well talk with real real estate brokers on the ground. well tell you where that house is, what it is going for, and we will show you it, later on "power lunch." ♪ [ male announcer ] don't just reject convention. drown it out. introducing the all-new 2013 lexus ls f sport. an entirely new pursuit. >>> welcome back to "power lunch." i'm bertha coombs and we have a lot of retailers looking good. bed bath and b
of money to develop them. but then again, we all have this problem with keeping health care costs down and obama care wants generic competition for biologics. what's the right road to take there? >> you know, joe, we've been in this industry for over 135 years. for us, we've taken a focus and we pursue both small molecule as well as bioological routes to address some of the most oppressing diseases out there. if you take alzheimer's, we have the biologic but we have a base inhibitor in phase two -- >> would you pay a lobbyist, would you get lobbyists for eli lilly to try to make it that you don't have to have generic competition for biologics, is that something eli lilly would do, or do you go along with it? >> well, remember, in the affordable care act we did get an extension in terms of data protection, as we should be, to at least 12 years. we believe that's very important for us to have a reasonable period to generate return on investment that we make in r&d. we still are the industry that invests the most in r&d, research and development, in this country. we from a policy standpoi
Search Results 0 to 1 of about 2